Education
About Us
Working with TipRanks
Follow Us
Regen Biopharma, Inc. (RGBP)
:RGBP
RGBP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.27
Previous CloseN/A
Volume4.72K
Average Volume (3M)166.51K
Market Cap
$1.21M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding31,554,705
10 Day Avg. Volume265,115
30 Day Avg. Volume166,509
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Regen Biopharma News
RGBP FAQ
What was Regen Biopharma, Inc.’s price range in the past 12 months?
Regen Biopharma, Inc. lowest stock price was $0.02 and its highest was $0.27 in the past 12 months.
What is Regen Biopharma, Inc.’s market cap?
Regen Biopharma, Inc.’s market cap is $1.21M.
When is Regen Biopharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regen Biopharma, Inc.’s earnings last quarter?
Currently, no data Available
Is Regen Biopharma, Inc. overvalued?
According to Wall Street analysts Regen Biopharma, Inc.’s price is currently Overvalued.
Does Regen Biopharma, Inc. pay dividends?
Regen Biopharma, Inc. does not currently pay dividends.
What is Regen Biopharma, Inc.’s EPS estimate?
Regen Biopharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regen Biopharma, Inc. have?
Regen Biopharma, Inc. has 31,554,705 shares outstanding.
What happened to Regen Biopharma, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regen Biopharma, Inc.?
Currently, no hedge funds are holding shares in RGBP
Company Description
Regen Biopharma, Inc.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
Regen Biopharma (RGBP) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Entero Therapeutics
―
Enveric Biosciences
―
Aditxt, Inc.
―
Protagenic Therapeutics
―
ELEVAI Labs Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---